WFDC9, or WAP four-disulfide core domain 9, is a protein encoded by the WFDC9 gene in humans. This protein belongs to the WFDC domain family, which is known for a characteristic motif that contains eight cysteine residues forming four disulfide bonds, conferring stability and resistance to proteolysis.The WFDC9 protein is of particular interest due to its presence in secretory fluids and extracellular matrix, suggesting a role in the body's defense mechanisms. Proteins within the WFDC domain family often participate in processes such as inflammation modulation, antimicrobial activity, and tissue remodeling. Therefore, WFDC9 could be integral to host protection and wound healing, though its precise functions and mechanisms of action remain to be fully elucidated.
The expression of WFDC9 is regulated both spatially and temporally, which implies that it may have specific roles in various tissues or under different physiological conditions. Given its potential involvement in protective mechanisms, changes in WFDC9 expression or function could be associated with pathological conditions, including inflammatory diseases, tissue repair disorders, and potentially cancer.Research into WFDC9 may focus on its molecular interactions and how it modulates the extracellular environment. Such studies could reveal its partners in signaling pathways and its effects on cellular behavior, such as proliferation, migration, and apoptosis.Understanding the activity of WFDC9 could provide insights into its contribution to homeostasis and the body's response to injury or infection. As an understudied member of the WFDC family, WFDC9 represents a promising avenue for research, which could eventually lead to novel targets for diseases where inflammation and extracellular matrix integrity are disrupted.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is known to activate adenylate cyclase, leading to increased cAMP levels, which can modulate various signaling pathways, potentially influencing WFDC9 activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX acts as a non-selective inhibitor of phosphodiesterases, elevating cAMP and cGMP levels in cells, which may indirectly affect WFDC9. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), and PKC activation can lead to varied cellular responses that might impact WFDC9 activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially influencing pathways that could affect WFDC9. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Similar to Ionomycin, A23187 is a calcium ionophore and could indirectly influence WFDC9 activity by altering calcium-dependent signaling pathways. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates various signaling pathways, including PI3K/Akt, which might have an indirect effect on WFDC9. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, but its use could indirectly affect WFDC9 activity through modulating downstream signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is involved in the MAPK/ERK pathway, potentially influencing WFDC9 activity indirectly. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, and this inhibition could lead to changes in cellular processes affecting WFDC9. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a central regulator of cell growth and metabolism, which might indirectly influence WFDC9 activity. | ||||||